The concept of an electronic pill has been around for decades. Many have imagined and even pursued a swallowed capsule with electronic function on board to measure, intervene, and/or deliver a drug while passing through the gastrointestinal tract.
Over the past few years, protein scientists have gradually adapted old techniques and developed a few new ones, yielding a new generation of tools that are finally starting to crack some of the field’s toughest problems.
The Pedant Cloud Service from Biomax Informatics offers the proven accuracy of the Pedant-Pro sequence analysis suite as a subscription service enabling researchers to load sequences and receive a complete genome analysis online.
CILS have introduced a solvent-resistant computer printable label range for HPLC columns, designed to permanently adhere to all surfaces and withstand aggressive HPLC cleaning agents, where traditional identification methods fail.
Aptuit announces the completion of the sale of the clinical trials supply business to Catalent Pharma Solutions. Aptuit will continue to deliver provide integrated capabilities for the early- to mid-phase drug development markets.
Aggressive ovarian tumors begin as malignant cells kept in check by the immune system until, suddenly and unpredictably, they explode into metastatic cancer.
Recordati and Nymox Pharmaceutical Corporation announced the start of preparations for a Phase 3 clinical trial for NX-1207, following the successful completion of a scientific advice meeting with the European Medicines Agency.
Plexxikon Inc., a member of Daiichi Sankyo Group, announced that the European Commission has approved Zelboraf for the monotherapy treatment of adult patients with BRAFV600 mutation-positive unresectable or metastatic melanoma.
A towering $60,000 bill, a year of fierce, flu-like symptoms, and a running risk of depression are among the possible costs of two new hepatitis C treatments. But according to new research, they might be worth it.
Aggressive infections in hospitals are a growing problem. Now, a scientist has found a natural substance in a Chilean rainforest plant that effectively supports the effect of traditional treatment with antibiotics.
Generic-drug company Mylan and the Pittsburgh Post-Gazette announced they have settled two lawsuits stemming from a series of stories that prompted a U.S. Food and Drug Administration review.
G-Biosciences' RED 660 Protein Assay is a single reagent colorimetric assay based on a proprietary dye-metal complex reagent.
Denator’s Stabilizor 2D-GE Extraction Kit, used alongside the Stabilizor system, enables users to heat-stabilize, homogenize and extract proteins from tissue samples following a validated protocol developed to maximize protein recovery.
The ability to automatically control stocks of consumables whilst processing samples can be a major time saver for busy laboratory managers. Two Fold Software Limited has added a Consumable Stock Control software module to its Version 1.1 release of Qualoupe LIMS software.